Among the matched cohorts of patients with T2D, 1093 (3.51%) GLP-1 RA nonusers and 480 (1.54%) users died during the follow-up period; the incidence rates of all-cause mortality were 13.06 and 5.67 per 1000 person-years, respectively (Table 2). The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.